|1.||Ito, Takashi: 4 articles (09/2015 - 01/2006)|
|2.||Azuma, Junichi: 4 articles (05/2008 - 01/2003)|
|3.||Schaffer, Stephen W: 3 articles (09/2015 - 01/2003)|
|4.||Häussinger, Dieter: 3 articles (04/2010 - 02/2002)|
|5.||Warskulat, Ulrich: 3 articles (04/2010 - 02/2002)|
|6.||Fujio, Yasushi: 3 articles (05/2008 - 01/2006)|
|7.||Uozumi, Yoriko: 3 articles (05/2008 - 01/2006)|
|8.||Takahashi, Kyoko: 3 articles (03/2006 - 01/2003)|
|9.||Desforges, M: 2 articles (04/2015 - 01/2013)|
|10.||Greenwood, S L: 2 articles (04/2015 - 01/2013)|
05/04/1995 - "Substrate-specific regulation of the taurine transporter in human placental choriocarcinoma cells (JAR)."
05/04/1995 - "Exposure of the JAR human placental choriocarcinoma cells to taurine leads to a marked decrease in the activity of the taurine transporter in these cells. "
07/01/1991 - "These data show that the choriocarcinoma cells express a taurine transporter with characteristics similar to those of the taurine transporter described in the normal human placenta, and that the activity of the transporter in these cells is under the regulatory control of protein kinase C."
04/01/2015 - "Maternal obesity is associated with a reduction in placental taurine transporter activity."
01/01/2013 - "Reduced placental taurine transporter (TauT) activity in pregnancies complicated by pre-eclampsia and maternal obesity."
09/01/2015 - "In this study, we investigated the effect of taurine depletion (in the taurine transporter (TauT) knockout mouse model) on blood glucose control and high fat diet-induced obesity. "
|3.||Wilms Tumor (Wilm's Tumor)
04/10/2003 - "In the present study we have demonstrated that WT1 (Wilms tumor suppressor gene) enhances the expression of TauT (taurine transporter gene) in human embryonic kidney 293 cells in a dose-dependent manner. "
01/01/2000 - "Further, the renal taurine transporter gene is down-regulated by the tumor suppressor gene p53, and up-regulated by the Wilms tumor (WT-1) and early growth response-1 (EGR-1) genes. "
|4.||Cardiomegaly (Heart Hypertrophy)
01/01/2003 - "Taurine transporter in cultured neonatal cardiomyocytes: a response to cardiac hypertrophy."
10/01/2002 - "To study the alterations of myocardial taurine transport function, taurine transporter (TAUT), and cysteine sulfinate decarboxylase (CSD) mRNA as well as effect of exogenous taurine in rats with isoproterenol (ISO)-induced cardiomegaly. "
01/01/2005 - "Our previous study indicated that taurine may play an inhibitory role against epilepsy as an inhibitory amino acid in the central nervous system and EA may inhibit epilepsy via up-regulating the expression of taurine transporter to increase the release of taurine. "
01/01/2005 - "The resulting data suggested that taurine may play an inhibitory role against epilepsy as an inhibitory amino acid in the central nervous system and EA may inhibit epilepsy via upregulating the concentration of taurine transporter to increase the release of taurine."
01/01/2005 - "We featured the dose-response relationship between taurine-treated epilepsy and epilepsy-only subjects, detected the effect of exogenous taurine on epilepsy and acupuncture treatment, and investigated taurine transporter immuno-activity in hippocampus using immunohistochemistry. "
01/01/2005 - "3), EA increased the concentration of taurine transporter in hippocampus by comparing EA-treated epilepsy with normal control and penicillin only, or EA-treated plus taurine-treated epilepsy with taurine-treated only epilepsy and penicillin only. "
|2.||Messenger RNA (mRNA)
|5.||Blood Glucose (Blood Sugar)
|6.||Ammonium Chloride (Sal Ammoniac)
|8.||Amino Acid Transport Systems (Amino Acid Transporter)
|10.||gamma-Aminobutyric Acid (GABA)